Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1999European Journal of Cardio-Thoracic Surgery

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer*1

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSalvatore U. BerlangieriAustin Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salvatore U. Berlangieri (1999) studied this question.

synapsesocial.com/papers/6a8646bd54e3ec4cc25ae97dhttps://doi.org/10.1016/s1010-7940(99)00179-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glucose utilization of cerebral gliomas measured by [ <sup>18</sup> F] fluorodeoxyglucose and positron emission tomography1982 · 757 citations
  2. 2Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.1992 · 271 citations
  3. 3Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.1997 · 378 citations
  4. 4Mediastinal Staging of Non-Small-Cell Lung Cancer With Positron Emission Tomography1995 · 167 citations